Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Catheter Equipment

PUBLISHER: Grand View Research | PRODUCT CODE: 1701399

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1701399

Interventional Oncology Market Size, Share & Trends Analysis Report By Technique, By Procedure, By Applications, By End-use, By Region, And Segment Forecasts, 2025 - 2030

PUBLISHED:
PAGES: 210 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Interventional Oncology Market Trends:

The global interventional oncology market size was valued at USD 2.68 billion in 2024 and is projected to grow at a CAGR of 8.55% from 2025 to 2030. This growth can be attributed to the increasing prevalence of cancer, increasing technological advancements in minimally invasive procedures, growing geriatric population, rising focus on early cancer detection, and increasing public and private investments in the field of interventional oncology. There is a significant rise in the number of cancer cases globally, increasing the need for advanced solutions facilitating better cancer care. According to the WHO, in 2022, approximately 20 million new cancer cases and 9.7 million deaths occurred. By 2050, cases are projected to rise to over 35 million, marking a 77% increase in the global cancer burden.

Interventional oncology, with its array of minimally invasive techniques such as radiofrequency ablation (RFA), transarterial chemoembolization (TACE), and cryoablation, offers significant advantages over traditional surgery, including reduced recovery times and lower complication rates. As the global cancer burden continues to rise, the adoption of these advanced interventional techniques is expected to accelerate, driven by their ability to improve patient outcomes and quality of life.

The rising global incidence of cancer is largely attributed to increasing tobacco use, unhealthy diets, alcohol consumption, air pollution, and physical inactivity. This surge in cancer cases poses a significant challenge for healthcare systems, spurring the development of advanced solutions that offer better results and outcomes. Interventional oncology, which provides a minimally invasive alternative to traditional cancer treatments such as surgery, radiation, and chemotherapy, has become increasingly popular. Its advantages in terms of reduced patient trauma and quicker recovery times are key factors driving market growth.

These staggering statistics highlight the urgent need for effective cancer treatments. Interventional oncology, with its array of minimally invasive techniques such as radiofrequency ablation (RFA), transarterial chemoembolization (TACE), and cryoablation, offers significant advantages over traditional surgery, including reduced recovery times and lower complication rates. As the global cancer burden continues to rise, the adoption of these advanced interventional techniques is expected to accelerate, driven by their ability to improve patient outcomes and quality of life.

Companies in the industry are actively pursuing various strategies to develop advanced solutions aimed at improving patient treatment and care. For example, in April 2021, Terumo launched its global therapeutic interventional oncology team to achieve excellence in interventional oncology solutions, with the goal of enhancing patient quality of life and survival rates. Such initiatives are expected to spur the development of innovative solutions, increasing the adoption of interventional oncology and driving market growth.

Moreover, increased efforts to develop advanced solutions have led to significant investments from both government and private organizations. In June 2023, Royal Philips announced that the Philips-coordinated IMAGIO consortium of clinical partners received a grant of approximately $25.97 million. This funding is intended to support research on minimally invasive cancer treatments, with a focus on liver cancer, lung cancer, and soft tissue sarcomas. Such investments are crucial for advancing interventional oncology technologies and improving patient outcomes.

Global Interventional Oncology Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global interventional oncology market report based on techniques, procedures, applications, end-use, and region.

  • Techniques Outlook (Revenue, USD Million, 2018 - 2030)
  • Ablation Therapies
    • Radiofrequency Ablation (RFA)
    • Microwave Ablation (MWA)
    • Cryoablation
    • Laser Ablation
    • Irreversible Electroporation (IRE)
  • Embolization Therapies
    • Transarterial Chemoembolization (TACE)
    • Transarterial Radioembolization (TARE)
  • Biopsy Techniques
    • Core Needle Biopsy
    • Fine Needle Aspiration (FNA)
  • Targeted Therapy Delivery Systems
    • Drug-Eluting Beads
    • Radioembolization
    • Drug-Eluting Stents
    • Injectable Hydrogels and Nanoparticles
    • Other Targeted Therapy Systems
  • Image-Guided Procedures
    • Ultrasound Guidance
    • CT Scan Guidance
    • MRI Guidance
    • Fluoroscopy Guidance
  • Procedure Outlook (Revenue, USD Million, 2018 - 2030)
  • Tumor Ablation
  • Tumor Biopsy
  • Vascular Interventions
  • Palliative Care
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Liver Cancer
  • Lung Cancer
  • Kidney Cancer
  • Prostate Cancer
  • Breast Cancer
  • Other Cancer
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Specialty Clinics
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: GVR-4-68040-363-1

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Technique Segment
    • 1.2.2. Procedure Segment
    • 1.2.3. Application Segment
    • 1.2.4. End-use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Interventional Oncology Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of cancer
      • 3.2.1.2. Increasing technological advancements in minimally invasive procedures
      • 3.2.1.3. Growing geriatric population
      • 3.2.1.4. Increasing focus on early cancer detection
      • 3.2.1.5. Increasing public and private investments in the field of interventional oncology
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost associated with interventional oncology
      • 3.2.2.2. Requirement of highly skilled professionals
  • 3.3. Interventional Oncology Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Interventional Oncology Market: Technique Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Interventional Oncology Market Product & Service Movement Analysis
  • 4.3. Global Interventional Oncology Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
  • 4.4. Ablation Therapies
    • 4.4.1. Ablation Therapies market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Radiofrequency Ablation (RFA)
      • 4.4.2.1. Radiofrequency Ablation (RFA) market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Microwave Ablation (MWA)
      • 4.4.3.1. Microwave Ablation (MWA) market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Cryoablation
      • 4.4.4.1. Cryoablation market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5. Laser Ablation
      • 4.4.5.1. Laser Ablation market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.6. Irreversible Electroporation (IRE)
      • 4.4.6.1. Irreversible Electroporation (IRE) market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Embolization Therapies
    • 4.5.1. Embolization Therapies market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Transarterial Chemoembolization (TACE)
      • 4.5.2.1. Transarterial Chemoembolzation (TACE) market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Transarterial Radioembolization (TARE)
      • 4.5.3.1. Transarterial Radioembolization (TARE) market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Biopsy Techniques
    • 4.6.1. Biopsy Techniques market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.2. Core Needle Biopsy
      • 4.6.2.1. Core Needle Biopsy market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.3. Fine Needle Aspiration (FNA)
      • 4.6.3.1. Fine Needle Aspiration (FNA) market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Targeted Therapy Delivery Systems
    • 4.7.1. Drug Delivery Systems market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.7.2. Drug-Eluting Beads
      • 4.7.2.1. Drug-Eluting Beads market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.7.3. Radioembolization
      • 4.7.3.1. Radioembolization market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.7.4. Drug-Eluting Stents
      • 4.7.4.1. Drug-Eluting Stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.7.5. Injectable Hydrogels and Nanoparticles
      • 4.7.5.1. Injectable Hydrogels and Nanoparticles market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.7.6. Other Targeted Therapy Systems
      • 4.7.6.1. Other Targeted Therapy Systems market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Image-Guided Procedures
    • 4.8.1. Image-Guided Procedures market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.8.2. Ultrasound Guidance
      • 4.8.2.1. Ultrasound Guidance market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.8.3. CT Scan Guidance
      • 4.8.3.1. CT Scan Guidance market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.8.4. MRI Guidance
      • 4.8.4.1. MRI Guidance market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.8.5. Fluoroscopy Guidance
      • 4.8.5.1. Fluoroscopy Guidance market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Interventional Oncology Market: Procedures Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Interventional Oncology Market Procedures Movement Analysis
  • 5.3. Global Interventional Oncology Market Size & Trend Analysis, by Procedures, 2018 to 2030 (USD Million)
  • 5.4. Tumor Ablation
    • 5.4.1. Tumor Ablation market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Tumor Biopsy
    • 5.5.1. Tumor Biopsy market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Vascular Interventions
    • 5.6.1. Vascular Interventions market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Palliative Care
    • 5.7.1. Palliative Care market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Interventional Oncology Materials Market: Applications Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Interventional Oncology Market Applications Movement Analysis
  • 6.3. Global Interventional Oncology Market Size & Trend Analysis, by Applications, 2018 to 2030 (USD Million)
  • 6.4. Liver Cancer
    • 6.4.1. Liver Cancer market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Lung Cancer
    • 6.5.1. Lung Cancer market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Kidney Cancer
    • 6.6.1. Kidney Cancer market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Prostate Cancer
    • 6.7.1. Prostate Cancer market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Breast Cancer
    • 6.8.1. Breast Cancer market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. Other Cancer
    • 6.9.1. Other Cancer market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Interventional Oncology Market: End-use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Interventional Oncology Market End Use Movement Analysis
  • 7.3. Global Interventional Oncology Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Hospitals
    • 7.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Specialty Clinics
    • 7.5.1. Specialty Clinics market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Interventional Oncology Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2023 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.4. North America
    • 8.4.1. U.S.
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Competitive scenario
      • 8.4.1.3. Regulatory framework
      • 8.4.1.4. Reimbursement scenario
      • 8.4.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.2. Canada
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Competitive scenario
      • 8.4.2.3. Regulatory framework
      • 8.4.2.4. Reimbursement scenario
      • 8.4.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.3. Mexico
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Competitive scenario
      • 8.4.3.3. Regulatory framework
      • 8.4.3.4. Reimbursement scenario
      • 8.4.3.5. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. UK
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Competitive scenario
      • 8.5.1.3. Regulatory framework
      • 8.5.1.4. Reimbursement scenario
      • 8.5.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. Germany
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Competitive scenario
      • 8.5.2.3. Regulatory framework
      • 8.5.2.4. Reimbursement scenario
      • 8.5.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. France
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Competitive scenario
      • 8.5.3.3. Regulatory framework
      • 8.5.3.4. Reimbursement scenario
      • 8.5.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.4. Italy
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Competitive scenario
      • 8.5.4.3. Regulatory framework
      • 8.5.4.4. Reimbursement scenario
      • 8.5.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.5. Spain
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Competitive scenario
      • 8.5.5.3. Regulatory framework
      • 8.5.5.4. Reimbursement scenario
      • 8.5.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.6. Norway
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Competitive scenario
      • 8.5.6.3. Regulatory framework
      • 8.5.6.4. Reimbursement scenario
      • 8.5.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.7. Sweden
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Competitive scenario
      • 8.5.7.3. Regulatory framework
      • 8.5.7.4. Reimbursement scenario
      • 8.5.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.8. Denmark
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Competitive scenario
      • 8.5.8.3. Regulatory framework
      • 8.5.8.4. Reimbursement scenario
      • 8.5.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Japan
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Competitive scenario
      • 8.6.1.3. Regulatory framework
      • 8.6.1.4. Reimbursement scenario
      • 8.6.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. China
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Competitive scenario
      • 8.6.2.3. Regulatory framework
      • 8.6.2.4. Reimbursement scenario
      • 8.6.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.3. India
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Competitive scenario
      • 8.6.3.3. Regulatory framework
      • 8.6.3.4. Reimbursement scenario
      • 8.6.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.4. Australia
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Competitive scenario
      • 8.6.4.3. Regulatory framework
      • 8.6.4.4. Reimbursement scenario
      • 8.6.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.5. South Korea
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Competitive scenario
      • 8.6.5.3. Regulatory framework
      • 8.6.5.4. Reimbursement scenario
      • 8.6.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.6. Thailand
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Competitive scenario
      • 8.6.6.3. Reimbursement scenario
      • 8.6.6.4. Regulatory framework
      • 8.6.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Brazil
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Competitive scenario
      • 8.7.1.3. Regulatory framework
      • 8.7.1.4. Reimbursement scenario
      • 8.7.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. Argentina
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Competitive scenario
      • 8.7.2.3. Regulatory framework
      • 8.7.2.4. Reimbursement scenario
      • 8.7.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. South Africa
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Competitive scenario
      • 8.8.1.3. Regulatory framework
      • 8.8.1.4. Reimbursement scenario
      • 8.8.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.2. Saudi Arabia
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Competitive scenario
      • 8.8.2.3. Regulatory framework
      • 8.8.2.4. Reimbursement scenario
      • 8.8.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.3. UAE
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Competitive scenario
      • 8.8.3.3. Regulatory framework
      • 8.8.3.4. Reimbursement scenario
      • 8.8.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.4. Kuwait
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. Competitive scenario
      • 8.8.4.3. Regulatory framework
      • 8.8.4.4. Reimbursement scenario
      • 8.8.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2023
  • 9.4. Company Profiles/Listing
    • 9.4.1. Medtronic plc
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Boston Scientific Corporation
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Johnson & Johnson (Ethicon)
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Baxter International Inc.
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Cook Medical
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. C.R. Bard Inc. (Acquired by BD)
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. AngioDynamics Inc.
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Stryker Corporation
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. B. Braun Melsungen AG
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Terumo Corporation
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives
    • 9.4.11. Siemens Healthineers
      • 9.4.11.1. Company overview
      • 9.4.11.2. Financial performance
      • 9.4.11.3. Product benchmarking
      • 9.4.11.4. Strategic initiatives
    • 9.4.12. GE Healthcare
      • 9.4.12.1. Company overview
      • 9.4.12.2. Financial performance
      • 9.4.12.3. Product benchmarking
      • 9.4.12.4. Strategic initiatives
Show more
Product Code: GVR-4-68040-363-1

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global interventional oncology market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 4 Global interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 5 Global interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 6 Global interventional oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 North America interventional oncology market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 9 North America interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 10 North America interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 11 North America interventional oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 U.S. interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 13 U.S. interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 14 U.S. interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 15 U.S. interventional oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Canada interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 17 Canada interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 18 Canada interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 19 Canada interventional oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Mexico interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 21 Mexico interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 22 Mexico interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 23 Mexico interventional oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Europe interventional oncology market, by country, 2018 - 2030 (USD Million)
  • Table 25 Europe interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 26 Europe interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 27 Europe interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 28 Europe interventional oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Germany interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 30 Germany interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 31 Germany interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 32 Germany interventional oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 UK interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 34 UK interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 35 UK interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 36 UK interventional oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 France interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 38 France interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 39 France interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 40 France interventional oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Italy interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 42 Italy interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 43 Italy interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 44 Italy interventional oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Spain interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 46 Spain interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 47 Spain interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 48 Spain interventional oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Denmark interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 50 Denmark interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 51 Denmark interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 52 Denmark interventional oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Sweden interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 54 Sweden interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 55 Sweden interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 56 Sweden interventional oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Norway interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 58 Norway interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 59 Norway interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 60 Norway interventional oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific interventional oncology market, by country, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific interventional oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 China interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 67 China interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 68 China interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 69 China interventional oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 70 Japan interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 71 Japan interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 72 Japan interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 73 Japan interventional oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 74 India interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 75 India interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 76 India interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 77 India interventional oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 78 South Korea interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 79 South Korea interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 80 South Korea interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 81 South Korea interventional oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 Australia interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 83 Australia interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 84 Australia interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 85 Australia interventional oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 86 Thailand interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 87 Thailand interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 88 Thailand interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 89 Thailand interventional oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 90 Latin America interventional oncology market, by country, 2018 - 2030 (USD Million)
  • Table 91 Latin America interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 92 Latin America interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 93 Latin America interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 94 Latin America interventional oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 95 Brazil interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 96 Brazil interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 97 Brazil interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 98 Brazil interventional oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 99 Argentina interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 100 Argentina interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 101 Argentina interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 102 Argentina interventional oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 103 MEA interventional oncology market, by country, 2018 - 2030 (USD Million)
  • Table 104 MEA interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 105 MEA interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 106 MEA interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 107 MEA interventional oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 108 South Africa interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 109 South Africa interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 110 South Africa interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 111 South Africa interventional oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia interventional oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 116 UAE interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 117 UAE interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 118 UAE interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 119 UAE interventional oncology market, by end-use, 2018 - 2030 (USD Million)
  • Table 120 Kuwait interventional oncology market, by technique, 2018 - 2030 (USD Million)
  • Table 121 Kuwait interventional oncology market, by procedure, 2018 - 2030 (USD Million)
  • Table 122 Kuwait interventional oncology market, by application, 2018 - 2030 (USD Million)
  • Table 123 Kuwait interventional oncology market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Interventional Oncology market: Market outlook
  • Fig. 5 Interventional Oncology market: Segment outlook
  • Fig. 6 Interventional Oncology market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Interventional Oncology market driver impact
  • Fig. 9 Interventional Oncology market restraint impact
  • Fig. 10 Interventional Oncology market: Technique outlook and key takeaways
  • Fig. 11 Interventional Oncology market: Technique movement analysis
  • Fig. 12 Ablation Therapies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 13 Radiofrequency Ablation (RFA) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Microwave Ablation (MWA) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Cryoablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Laser Ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Irreversible Electroporation (IRE) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Embolization Therapies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Transarterial Chemoembolization (TACE) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Transarterial Radioembolization (TARE) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Biopsy Techniques market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Core Needle Biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Fine Needle Aspiration (FNA) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Targeted Therapy Delivery Systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Drug-Eluting Beads market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Radioembolization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Drug-Eluting Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Injectable Hydrogels and Nanoparticles market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Other Targeted Therapy Systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Image-Guided Procedures market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Ultrasound Guidance market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 CT Scan Guidance market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 MRI Guidance market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Fluoroscopy Guidance market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Interventional Oncology market: Procedure outlook and key takeaways
  • Fig. 36 Interventional Oncology market: Procedure movement analysis
  • Fig. 37 Tumor Ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Tumor Biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Vascular Interventions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Palliative Care market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Interventional Oncology market: Application outlook and key takeaways
  • Fig. 42 Interventional Oncology market: Application movement analysis
  • Fig. 43 Liver Cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Lung Cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Kidney Cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Prostate Cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Breast Cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Other Cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Interventional Oncology market: End-use outlook and key takeaways
  • Fig. 50 Interventional Oncology market: End-use movement analysis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Specialty Clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Other market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Global Interventional Oncology market: Regional outlook and key takeaways
  • Fig. 56 Global Interventional Oncology market: Regional movement analysis
  • Fig. 57 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Target Disease Prevalence
  • Fig. 61 Key country dynamics
  • Fig. 62 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 Key country dynamics
  • Fig. 99 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 100 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 101 Key country dynamics
  • Fig. 102 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 103 Key country dynamics
  • Fig. 104 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 105 Key country dynamics
  • Fig. 106 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 107 Key country dynamics
  • Fig. 108 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!